Last reviewed · How we verify

NCT05006495

Comparison Between C3-6 Laminoplasty and C3 Laminectomy With Cervical Laminoplasty

Completed NA Results posted Last updated 21 June 2024
What this trial tests

NA trial testing C3 laminectomy in Myelopathy Cervical in 126 participants. Completed in 28 October 2022.

Timeline
20 March 2017
Primary endpoint
28 October 2022
28 October 2022

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment126
Start date20 March 2017
Primary completion28 October 2022
Estimated completion28 October 2022
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

Adults 20 to 80, any sex, with Myelopathy Cervical or Kyphosis Post Surgical. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

C2-C7 Lordosis Primary · at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)

Measuring C2-C7 lordosis angle by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty11.0± 0.8
C3-6 Laminoplasty10.9± 0.8
the Neck Disability Index (NDI) Primary · at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)

scores from 0 to 50 with 50 being the worst performance status related to neck pain.

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty12.8± 1.0
C3-6 Laminoplasty8.6± 1.0
C2-C3 Lordosis Secondary · at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)

Measuring C2-C3 lordosis by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty7.1± 0.5
C3-6 Laminoplasty3.2± 0.5
C4-C7 Lordosis Secondary · at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)

Measuring C4-C7 lordosis by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty3.9± 0.8
C3-6 Laminoplasty7.7± 0.7
Cervical Sagittal Vertical Axis (cSVA) Secondary · at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)

Measuring cervical sagittal vertical axis by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty31.6± 1.4
C3-6 Laminoplasty25.5± 1.3
T1 Slope Secondary · at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)

Measuring T1 slope by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty25.8± 0.6
C3-6 Laminoplasty25.3± 0.6
T1 Slope Minus Cervical Lordosis Secondary · at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)

Measuring T1 slope minus cervical lordosis by using standard lateral cervical x-ray series protocol with the patients standing in a neutral position and instructed to look straight ahead with knees locked.

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty15.0± 1.0
C3-6 Laminoplasty14.9± 0.9
C2-C3 Interlaminar Spontaneous Fusion Secondary · at 2 year

Measuring the incidence of postoperative C2-C3 interlaminar spontaneous fusion by using standard lateral cervical x-ray series.

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty5
C3-6 Laminoplasty26
EuroQol Five-dimensional Questionnaire (EQ-5D) Scores Secondary · at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)

Responses on a questionnaire with five dimensions, each comprised of five levels. Scores are revised into an index with a range from -0.59-1, with 1.00 indicating full health. The 243 possible health states on the EQ-5D are evaluated against a normal population using the time trade off method (TTO).

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty0.661± 0.025
C3-6 Laminoplasty0.743± 0.024
Posterior Neck With Numering Rating Scale (NRS-N) Secondary · at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)

Measuring pain intensity of the posterior neck with numeric rating scale (NRS), rated 1 to 10 with 10 being the most severe pain level.

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty2.8± 0.3
C3-6 Laminoplasty2.0± 0.3
Upper Limb Pain With Numering Rating Scale (NRS-L) Secondary · at 1, 2, 3 year (linear mixed-effect model analysis was used for repeated measurements)

Measuring pain intensity of the upper limb with numeric rating scale (NRS), rated 1 to 10 with 10 being the most severe pain level.

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty3.7± 0.4
C3-6 Laminoplasty2.8± 0.3
Estimated Intraoperative Blood Loss Secondary · Intraoperative

Measuring estimated intraoperative blood loss by using intraoperative records of anesthesiologists.

GroupValue95% CI
C3 Laminectomy With C4-6 Laminoplasty169± 145
C3-6 Laminoplasty182± 159

Sponsor's own description

Investigators performed a prospective randomized controlled trial for comparing postoperative clinical and radiological outcomes between C3 laminectomy with laminoplasty and C3-6 laminoplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Myelopathy Cervical

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05006495.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing